Surgical Bone
Substitute
& Regeneration
Kervalion,
a key player in the future
biomaterials
biomaterials
dental
KERVALION develops 3D-printed bone grafts, custom-designed from patient scans.
Initially intended for pre-implant dental surgery, these grafts are designed to treat bone deficits that prevent the placement of dental implants. Thanks to customized manufacturing, they adapt perfectly in shape and volume, simplifying surgery and reducing the number of surgical procedures required. KERVALION's innovative material guarantees excellent tolerance, while promoting reliable bone regeneration.
This technology offers practitioners an easier, faster and more cost-effective solution, making grafting accessible to a greater number of professionals, while improving patient comfort.
A public health issue
Permanent tooth decay affects over 2 billion people worldwide, and every year 2 million dental implants are placed in Europe.
Bone reconstruction in pre-implant surgery: known limitations
Current bone reconstruction methods include:
- Autografting, considered the "gold standard"
- Allografts (of human, animal or synthetic origin)
However, these techniques have a number of drawbacks:
- They require the intervention of specialized surgeons
- They involve several operations (3 to 4 on average)
- They require a long treatment time (6 to 12 months)
- They generate significant costs (up to €1,500)
- They carry a risk of infection
- They have a significant failure rate (10 to 20%)
These limitations call for a more rapid, efficient and accessible approach to meet the growing needs of patients and professionals alike.
Kervalion innovation in dental bone reconstruction
KERVALION offers a novel, ready-to-use solution for the treatment of patients suffering from dental bone resorption. Thanks to 3D printing, we can design personalized bone substitutes, tailored to each individual patient. KERVALION uses 3D printing to shape the biomaterial, enabling unrivalled precision in graft manufacture. This advanced technique guarantees a bone graft with optimal biological and mechanical properties, essential for graft success. This innovative approach promises to revolutionize the field of pre-implant surgery, offering a tailor-made, effective and less invasive solution for patients requiring bone reconstruction prior to the placement of dental implants.
The key benefits of our innovation :
Personalization made-to-measure :
The graft is designed from a CT scan for perfect morphological adaptation, optimizing integration and results.
Properties antibacterial :
KERVALION material incorporates an antibacterial treatment, reducing the risk of post-operative infection and promoting better healing.
A single surgical surgical procedure :
The technology makes it possible to reduce the procedure to a single surgical act, considerably reducing treatment time and inconvenience for the patient.
Performance biomechanical :
KERVALION
bone substitute offers biological and mechanical properties equivalent or superior to existing solutions, ensuring effective and efficient bone regeneration.
The global market for dental bone graft substitutes
The global market for dental bone grafts is growing significantly, with a compound annual growth rate (CAGR) of between 6.8% and 9.2%, reflecting the increasing importance of bone reconstruction procedures in the dental field.
In Europe :
703,420 dental bone grafting procedures were carried out in the main countries (Germany, France, Italy, Spain, England), underlining the substantial demand on the continent.
United States:
the market is particularly dynamic, with 1,651,091 procedures carried out, making it the world leader in this field. This strong demand is due to an advanced healthcare infrastructure and increased awareness
of oral health
.
Emerging markets :
they also show considerable potential. Brazil, Russia, India and China collectively performed 1,285,033 procedures, indicating a growing adoption of dental bone grafting techniques in these regions.
One notable trend is the expected growth of the synthetic graft market, which is expected to post the strongest growth between now and 2030.
The global market for dental bone grafts is experiencing significant growth, driven by increased demand for dental implants and technological advances.
The global market for dental bone grafts is growing significantly, with a compound annual growth rate (CAGR) of between 6.8% and 9.2%, reflecting the increasing importance of bone reconstruction procedures in the dental field.
Roadmap
The team
Habib BELAID
Co-founder & CEO
Fanny BARRANGER
Materials Chemistry Engineer
Aurélien BON
3D Design Engineer
Marilyn Kajdan
Biological engineer
Mikhael BECHELANY
Co-founder & Materials Research Manager
David CORNU
Co-founder & University Professor of Materials
Vincent CAVAILLES
Co-founder & Director of Biology Research
Gilles Devillers
Co-founder & Managing Director
Chief Business Officer
Our social and environmental commitments
KERVALION is committed to providing innovative medical solutions while minimizing its environmental impact, demonstrating
that it is possible to combine medical progress and ecological responsibility.
A strong social impact
KERVALION is committed to providing innovative medical solutions while minimizing its environmental impact, demonstrating
that it is possible to combine medical progress and ecological responsibility.
Local production and made in France: we work with local suppliers and service providers to promote the national economy while reducing our carbon footprint. Controlled 3D printing: manufacturing unique parts with optimized resources and reduced waste.
Biobased raw materials: materials that respect the environment and health, limiting the use of human bone banks
.
Optimized logistics: reducing the number and duration of transports.
An eco-responsible model
Partners
